Trials Group Of The Year: King & Spalding
King & Spalding LLP's trial team successfully defended drugmaker Boehringer Ingelheim in the first trial over claims alleging Zantac contributed to patients' cancer, as well as Johnson & Johnson in its...To view the full article, register now.
Already a subscriber? Click here to view full article